Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma

Oncotarget

Volumn 4, Issue 11, 2013, Pages 2135-2143

  Zhang, Hao ^a   Lin, Wan ^a   Kannan, Kalpana ^b   Luo, Liming ^b   Li, Jing ^a   Chao, Pei Wen ^b   Wang, Yan ^b   Chen, Yu Ping ^a   Gu, Jiang ^a   Yen, Laising ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer biomarker; Esophageal cancer; GOLM1 MAK10; Secreted fusion protein; Transcription induced chimeric RNAs; Transcriptome

Indexed keywords

CHIMERIC PROTEIN; GOLM1 PROTEIN; GOLPH2 PROTEIN; HYBRID PROTEIN; MAK10 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GOLM1 GENE; HIGH THROUGHPUT SEQUENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAK10 GENE; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHIMERISM; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; N-TERMINAL ACETYLTRANSFERASE C; ONCOGENE PROTEINS, FUSION; PROGNOSIS; RNA; TRANSCRIPTOME; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84890243733     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1465     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2): 74-108.
2. Parkin DM, Bray F, Ferlay J and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94:153-56.
3. Enzinger PC and Mayer RJ. Esophageal cancer. N Engl J Med. 2003; 349(23):2241-52.
4. Gingeras TR. Implications of chimaeric non-co-linear transcripts. Nature. 2009; 461(7261):206-11.
5. Kaye FJ. Mutation-associated fusion cancer genes in solid tumors. Mol Cancer Ther. 2009; 8(6):1399-408.
6. Kannan K, Wang L, Wang J, Ittmann MM, Li W and Yen L. Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proc Natl Acad Sci U S A. 2011; 108(22):9172-77.
7. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N and Chinnaiyan AM. Transcriptome sequencing to detect gene fusions in cancer. Nature. 2009; 458(7234):97-101.
8. Rickman DS PD, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F and Rubin MA. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Res. 2009; 69:2734-38.
9. Frenkel-Morgenstern M, Lacroix V, Ezkurdia I, Levin Y, Gabashvili A, Prilusky J, Del Pozo A, Tress M, Johnson R, Guigo R and Valencia A. Chimeras taking shape: potential functions of proteins encoded by chimeric RNA transcripts. Genome research. 2012; 22(7):1231-42.
10. Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006; 355(23):2408-17.
11. Cheung PY, Deng W, Man C, Tse WW, Srivastava G, Law S, Tsao SW and Cheung AL. Genetic alterations in a telomerase-immortalized human esophageal epithelial cell line: implications for carcinogenesis. Cancer Lett. 2010; 293(1):41-51.
12. Hu YC, Lam KY, Law SY, Wan TS, Ma ES, Kwong YL, Chan LC, Wong J and Srivastava G. Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer genetics and cytogenetics. 2002; 135(2):120-27.
13. Zhang H, Singh RR, Talukder AH and Kumar R. Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Gene Dev. 2006; 20(21):2943-48.
14. Gong Y, Long Q, Xie H, Zhang T and Peng T. Cloning and characterization of human Golgi phosphoprotein 2 gene (GOLPH2/GP73/GOLM1) promoter. Biochem Biophys Res Commun. 2012; 421(4):713-20.
15. Nonn L, Ananthanarayanan V and Gann PH. Evidence for field cancerization of the prostate. The Prostate. 2009; 69(13):1470-79.
16. Kim HJ, Lv D, Zhang Y, Peng T and Ma X. Golgi phosphoprotein 2 in physiology and in diseases. Cell&bioscience. 2012; 2(1):31.
17. Hu N, Clifford RJ, Yang HH, Wang C, Goldstein AM, Ding T, Taylor PR and Lee MP. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC genomics. 2010; 11:576.
18. Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran S, Tomlins SA, Granger J, Vellaichamy A, Sreekumar A, Yu JJ, Gu WJ, Shen RL, Ghosh D, Wright LM, Kladney RD, Kuefer R, et al. Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer. Neoplasia. 2008; 10(11):1285-U1104.
19. Oh JJ, Grosshans DR, Wong SG and Slamon DJ. Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells. Nucleic acids research. 1999; 27(20):4008-17.
20. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS and Block TM. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol. 2005; 43(6):1007-12.
21. Mao YL, Yang HY, Xu HF, Lu X, Sang XT, Du SD, Zhao HT, Chen W, Xu Y, Chi TY, Yang ZY, Cai JQ, Li H, Chen JG, Zhong SX, Mohanti SR, et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 2010; 59(12):1687-93.
22. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA and Chinnaiyan AM. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005; 310(5748):644-48.
23. Fritzsche FR, Kristiansen G, Riener MO, Dietel M and Oelrich B. GOLPH2 expression may serve as diagnostic marker in seminomas. Bmc Urol. 2010;10.
24. Tihan T, Harmon JW, Wan X, Younes Z, Nass P, Duncan KL and Duncan MD. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer research. 2001; 21(4B):3107-14.